The first patent application on the basic concept of PexyEazy® is accepted in USA, Japan, Singapore, Russia, South Africa, Israel and China. The international patent

First PexyEazy® procedure on human, as the first patient participated in the SCI-Pex study, a safety and feasibility study on PexyEazy®. A total of 35

Developeration AB was awarded “Seal of Excellence” by the European Commission as part of the application for Horizon EIC 2022 Accelerator grant. Our application was

Developeration AB was awarded by the Scandinavian Business Awards as the “Most Innovative Operation Research & Development Company – Sweden”. https://www.eubusinessnews.com/winners/developeration-ab/

ALMI Invest, STOAF, Rentability AB, Adiuvero AB and GAEU Venture AB invest I Developeration AB’s second investment round, in total 11,5 MSEK.

Developeration has been acknowledged as the “Best Medical Devices Developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners-list/?award=11481-2021

Developeration AB is accepted to the EIT Health Investor Network as a GOLD Company.

A second patent application is filed directly as a EU-patent.

Developeration has been acknowledged as the “Most innovative medical devices developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners/developeration-ab/

2020-09-15 ALMI Invest and STOAF, invest in Developeration AB, in total 4,4MSEK. https://stoaf.se/2020/09/15/stoaf-invests-in-developerations-innovative-surgical-device/ 

Developeration AB receives 2,56MSEK in funding for product development and clinical investigations from Sthlm Life Scale-Up Program from Region Stockholm, KI Innovations AB and Tillväxtverket.

Developeration’s novel device PexyEazy for the surgical treatment of haemorrhoids has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement

Developeration AB become a member of the Karolinska Institutet Innovations incubator programme, DRIVE. https://www.lifesciencesweden.se/article/view/599332/ki_innovations_valjer_ut_bolag http://www.mynewsdesk.com/se/karolinska-institutet-innovations-ab/pressreleases/nu-erbjuder-vi-starkare-stoed-till-innovativa-bolag-inom-life-science-2492287

Developeration AB receives funding from Novo nordisk fonden, Exploratory Pre-seed.

Developeration AB receives funding from EIT Health, Proof of Concept.

Developeration AB receives funding from Vinnova, “Innovativa Startups, fas 1”, for further development of PexyEazy, a new operation method for treatment of haemorrhoids. https://www.vinnova.se/p/pexyeazy—en-ny-operationsmetod-for-behandling-av-hemorrojder/ 

Developeration AB participate in the program for entrepreneur, STING (Stockholm Innovation & Growth) Test Drive Health. http://www.mynewsdesk.com/se/stockholm_innovation___growth__sting/pressreleases/13-innovativa-haelsostartups-utvalda-till-sting-test-drive-1745877

Developeration AB receives funding from Vinnova for development of a new operation methods for treatment of haemorrhoids. http://www.vinnova.se/sv/Resultat/Projekt/Effekta/2009-02172/Utveckling-av-nytt-operationsinstrument-for-behandling-av-hemorrojder/